Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|20|3662-3671

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.20, 2013-10, pp. : 3662-3671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous stem cell transplantation with in vivo purged progenitor cells shows long‐term efficacy in relapsed/refractory follicular lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : 230-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 132-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : E145-E145

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B‐cell lymphoma not eligible for autologous stem cell transplantation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 663-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prolonged Remission in a Patient with Relapsed Follicular Lymphoma after a Single Course of Rituximab

By  

Oncology Research and Treatment, Vol. 29, Iss. 3, 2006-03 ,pp. : 90-92

Karger

Access to resources Recommend Favorite